SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001140361-19-011159
Filing Date
2019-06-17
Accepted
2019-06-17 17:15:55
Documents
5

Document Format Files

Seq Description Document Type Size
1 FORM S-3 nt10002595x1_s3.htm S-3 477639
2 EXHIBIT 5.1 nt10002595x1_ex5-1.htm EX-5.1 24499
3 EXHIBIT 23.1 nt10002595x1_ex23-1.htm EX-23.1 2214
4 logo_rocketpharma.jpg GRAPHIC 28940
5 nt10002595x1_ex5-1logo.jpg GRAPHIC 138739
  Complete submission text file 0001140361-19-011159.txt   736305
Mailing Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118
Business Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118 646-440-9100
ROCKET PHARMACEUTICALS, INC. (Filer) CIK: 0001281895 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-232168 | Film No.: 19902096
SIC: 2834 Pharmaceutical Preparations